Bio-Reference Laboratories, Inc. Announces Kansas Correctional Healthcare Contract
Bio-Reference Laboratories, Inc. announced effective June 7, 2004, it has begun providing laboratory services for Correct Care Solutions (CCS) under their contract with the Kansas Department of Corrections (KDOC). CCS took over the contract with the KDOC October 1, 2003 and CCS has contracted with Bio-Reference to provide clinical laboratory services. This contract represents a significant geographical push for Bio-Reference since it is the first correctional healthcare contract pursuant to which Bio-Reference has agreed to provide services west of the Mississippi River.
Jerry Boyle, President and CEO of CCS, commented “We are pleased to be working with Bio Reference Laboratories in the provision of quality laboratory services for the Kansas Department of Corrections”.
Marc D. Grodman M.D., President noted, “Kansas represents a great opportunity for Bio-Reference Laboratories, not just in the correctional healthcare market, but in our efforts to get greater recognition for our national presence in all of our focused specialty services. We are pushing our geographical boundaries in all of our focused specialty services and expanding correctional healthcare into Kansas highlights the implementation of our strategy.”
About Bio-Reference Laboratories, Inc.
The Company is the largest independent regional clinical laboratory in the Northeast and has major market positions in physician offices, nursing homes and correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health, and complimentary medicine. PSIMedica, a business unit of the Company, is a clinical knowledge management (CKM) organization offering an array of information solutions for reducing healthcare costs and improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information, including claims data, enrollment data, prescription data and laboratory data. The Company provides a comprehensive connectivity solution to physicians, which includes disease management, laboratory reporting and ordering, as well as claims and eligibility processing through CareEvolve, its web-based healthcare portal.
Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as “forward-looking statements”. Statements looking forward in time are included in this release pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks and uncertainties that may cause the Company’s actual results in future periods to be materially different from any future performance suggested herein.
